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Abstract
Background: This study compares prevalence and types of medical end-of-life decisions between
the Dutch-speaking and French-speaking communities of Belgium. This is the first nationwide study
that can make these comparisons and the first measurement after implementation of the euthanasia
law (2002).
Methods: We performed a mortality follow-back study in 2005–2006. Data were collected via the
nationwide Sentinel Network of General Practitioners, an epidemiological surveillance system
representative of all Belgian GPs.
Weekly, all GPs reported the medical end-of-life decisions among all non-sudden deaths of patients
in their practice. We compared the northern Dutch-speaking (60%) and southern French-speaking
communities (40%) controlling for population differences.
Results: We analysed 1690 non-sudden deaths. An end-of-life decision with possible life-
shortening effect was made in 50% of patients in the Dutch-speaking community and 41% of
patients in the French-speaking community (OR 1.4; 95%CI, 1.2 to 1.8). Continuous deep sedation
until death occurred in 8% and 15% respectively (OR 0.5; 95%CI, 0.4 to 0.7). Community
differences regarding the prevalence of euthanasia or physician-assisted suicide were not significant.
Community differences were more present among home/care home than among hospital deaths:
non-treatment decisions with explicit life-shortening intention were made more often in the
Dutch-speaking than in the French-speaking community settings (OR 2.2; 95%CI, 1.2 to 3.9); while
continuous deep sedation occurred less often in the Dutch-speaking community settings (OR 0.5;
95%CI, 0.3 to 0.9).
Conclusion: Even though legal and general healthcare systems are the same for the whole
country, there are considerable variations between the communities in type and prevalence of
certain end-of-life decisions, even after controlling for population differences.
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Several studies have shown that death is often preceded by
a medical end-of-life decision with possible or certain life-
shortening effect such as non-treatment decisions, inten-
sification of symptom alleviation, euthanasia, physician-
assisted suicide, or the use of lethal drugs without the
patient's explicit request [1-20]. Both the incidence and
the characteristics of the decision-making process have
been found to differ between countries [4,7,14,16,20,21].
However, even when using the same methodology in
international comparative research, interpretation of dif-
ferences between countries is very difficult since totally
different legal and healthcare systems need to be com-
pared.
Belgium is a unique country in which to study variations
in end-of-life decision-making. It is one country, where
legal and general healthcare structures (e.g. social security
system, accessibility criteria for healthcare provision, gen-
eral healthcare budget) are defined and regulated at
national level, but where two language communities can
be differentiated: the Dutch-speaking northern commu-
nity (60% of the population) and the French-speaking
southern community (40%), both separately responsible
for policy concerning culture, education, and certain
aspects of healthcare (e.g. prevention, organisation of
healthcare) [22-26]. The investigation of whether varia-
tions in end-of-life decisions occur under these circum-
stances can give important insights into the factors
underlying them.
Furthermore, Belgium is one of the three countries in the
world with a law on euthanasia [22]. Notification of
euthanasia cases is legally obligatory. However, despite
having the same legal system, it is remarkable that 82% of
all cases reported to the Federal Evaluation and Control
Committee on Euthanasia in 2005 and 2006 came from
Dutch-speaking physicians, while only 18% came from
French-speaking physicians [27-29]. The largest propor-
tional difference was found for patients who died at home
or in care homes (92%-8%) compared to hospital settings
(81%-19%) [29]. Because this cannot be explained by dif-
ferences in population size, finding empirically-supported
explanations has become an issue of considerable medical
and societal debate. It also raises questions concerning
differences in other end-of-life decisions in homecare and
hospital settings.
Previous reports concerning end-of-life decision-making
in Belgium could not make comparisons between the two
communities. Due to the absence of recent death certifi-
cates in the French-speaking community which would
identify physicians, previous reports only cover the
Dutch-speaking community [3,4]. Additionally, these fig-
ures date from the time before the euthanasia law was
implemented in 2002 [3,4,22].
The objective of this study is to investigate possible differ-
ences in prevalence and types of end-of-life decisions
between the Dutch-speaking and French-speaking com-
munities of Belgium after the implementation of the
euthanasia law. We focus on three research questions.
How prevalent are different types of end-of-life decisions
in Belgium in 2005–2006? Are there differences between
the two communities in the prevalence of different types
of end-of-life decisions or in the decision-making process?
Are these differences present in homecare settings as well
as in hospital settings in both communities?
Methods
Design
Because general practitioners (GPs) are pivotal healthcare
providers in Belgium and 95% of the population, includ-
ing care home residents, have a regular GP [30], we collab-
orated with the existing nationwide Belgian Sentinel
Network of General Practitioners to study a population-
based sample of deaths in Belgium. This network, opera-
tional since 1979, has proved to be a reliable surveillance
system for a wide variety of health-related epidemiologi-
cal data [31-33]. In 2005 and 2006, it consisted of respec-
tively 181 and 174 regularly participating practices,
representative of all 10,578 GPs in Belgium in terms of
age, gender and region and covering 1.75% of the total
Belgian patient population [31,34].
In 2005 and 2006, this network participated in a two-year
nationwide mortality follow-back study, the senti-melc
study, which was designed to monitor end-of-life care via
this sentinel GP Network [33]. The GPs from the sentinel
network registered weekly all deaths of patients in their
practice older than one year, including deaths that
occurred in hospital settings. They registered each death
immediately it occurred or immediately on being
informed, using a standardised form. If patients died in a
hospital setting, GPs were informed by the hospital spe-
cialists.
Anonymity of the patient and the physician was pre-
served. Every patient that is registered within the network
received an anonymous reference from the GP him/her-
self, and all identification codes of the GPs were replaced
in the data files with anonymous codes during data clean-
ing. Details of this procedure are described elsewhere [33].
The study protocol was approved by the Ethical Review
Board of Brussels University Hospital.
Measurements
The first part of the registration surveyed the patient char-
acteristics of all registered patients and whether or not
death had occurred "suddenly and totally unexpectedly"
[4,35]. For patients who died non-suddenly, a second part
surveyed end-of-life decision-making. Following previous
studies [3,4] we studied 4 types of end-of-life decisionsPage 2 of 10
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the responding GP him/herself or by another physician:
(1) non-treatment decisions (taking into account a possi-
ble hastening of death or with the explicit intent to hasten
death); (2) intensifying alleviation of pain or other symp-
toms (taking into account or co-intending the hastening
of death); (3) administering (i.e. euthanasia), supplying
or prescribing (i.e. physician-assisted suicide) drugs with
the explicit intention of hastening death on the patients'
explicit request; and (4) administering drugs with the
explicit intention of hastening death without explicit
patient request. Concerning the decision-making process,
we investigated whether the decision was taken after dis-
cussion with the patient, on his/her explicit request, and
whether the patient was competent to make decisions.
The GPs were instructed to fill in these questions only if
one of the questions on end-of-life decisions was
answered "yes".
Finally, we also asked whether or not continuous deep
sedation was performed, defined as a patient being deeply
and continuously sedated or in a coma until death, by
means of e.g. benzodiazepines or barbiturates (continu-
ous deep sedation) and if so, whether artificial food or
fluid was administered (palliative sedation) or not (termi-
nal sedation). The wording of all questions and classifica-
tion of practices was identical to previous incidence
studies although these used another research design [1-
4,10,17].
The instrument was first developed in Dutch and then
translated into French via forward-backward translation.
It was tested and slightly adapted after an extensive pilot
study [33]. Several control measures were used to ensure
data quality: automatic follow-up and possible telephone
contact with the GP to prevent missing data for key varia-
bles (e.g. euthanasia), data-entry with consistency, range
and skip checks, and double data-entry.
Detailed descriptions of the SENTI-MELC study's method-
ology, the questionnaire and first set of results have previ-
ously been reported [33,36-38].
Analysis
We calculated the prevalence of end-of-life decisions for
Belgium using binominal 95% confidence intervals (exact
method). To analyse differences between the communi-
ties in Belgium, we compared cases from physicians in the
Dutch-speaking northern part with cases from physicians
in the French-speaking southern part. We used logistic
regression analysis to calculate odds-ratios correcting for
differences in patient characteristics. Interaction effects
between community and each patient characteristic were
systematically evaluated. We studied differences between
the communities in total, as well as for homecare and hos-
pital settings separately subdivided on the basis of the
patient's place of death. Differences in decision-making
characteristics were studied using Fishers' Exact Tests. All
analyses were performed using StatXact6 (Cytel Studio,
Cambridge, MA) and SPSS14.0 (SPPS Inc, Chicago, IL).
Results
Study population
The GPs reported 2690 deaths, of which 64.3% were non-
sudden. Forty-one cases (2.4%) were excluded from the
SENTI-MELC study because of missing data. Thus, the
results are based on 1690 non-sudden deaths, described
in Table 1. Age, sex, educational level, cause of death and
place of death for non-sudden deaths did not differ
between the two communities (p > .05). Age, sex and
place of death for non-sudden deaths in Flanders (N =
1032) could be compared with non-sudden deaths iden-
tified in a previous study on end-of-life practices repre-
sentative of all deaths in this same part of the country (n
= 2128) [4]. There were no significant differences for these
characteristics (binomial 95% CI, exact method).
Frequencies of end-of-life practices
In 47% of all patients who died non-suddenly, death was
preceded by an end-of-life decision with possible life-
shortening effect in Belgium (Table 2). This involved
euthanasia/physician-assisted suicide in 1.3% of cases,
life-ending drug use without the patient's explicit request
in 1.6%, intensified symptom alleviation in 28%, and
non-treatment decisions in 16% of cases. Continuous
deep sedation was registered in 11% of cases in total, for
which 6% and 5% respectively involved the administra-
tion and forgoing of artificial food or fluid.
Controlling for differences in patient age, sex, educational
level, cause of death and place of death, the chance of
dying following a possibly life-shortening end-of-life deci-
sion was higher in the Dutch- (50%) than in the French-
speaking community (41%) of Belgium (OR 1.4; 95% CI,
1.2 to 1.8) (Table 2). Selecting all end-of-life decisions
with a partly or explicitly life-shortening intention, this
difference remained significant (OR 1.4; 95% CI, 1.1 to
1.9). We found higher frequencies for all types of end-of-
life decisions with possible life-shortening effect in the
Dutch- than in the French-speaking community, but dif-
ferences did not reach significance at a 95% confidence
interval level for any specific type. Euthanasia or physi-
cian-assisted suicide (PAS) was performed in 1.6% and
0.9% of cases in the Dutch- and French-speaking commu-
nity respectively (OR non-significant). Continuous deep
sedation both while administering and forgoing food/
fluid was registered less often in the Dutch- (8%) than in
the French-speaking community (15%) (OR 0.5; 95% CI,
0.4 to 0.7).
Table 3 describes these end-of-life decisions separately for
patients who died in the home or care home and forPage 3 of 10
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care home, end-of-life decisions with possible life-short-
ening effect, especially non-treatment decisions with
explicit life-shortening intent, were taken more often in
the Dutch- (10%) than in the French-speaking commu-
nity (5%). Euthanasia/PAS occurred in 1.6% and 1.1% of
cases in the Dutch- and French-speaking community
respectively (OR non-significant). Continuous deep seda-
tion was performed less frequently in the Dutch- than in
the French-speaking homes/care homes (4% versus 8%).
Differences for sedation while forgoing food/fluid
reached significance at a 90% confidence interval level.
In the hospital, community differences for end-of-life
decisions with possible life-shortening effect were never
statistically significant. Continuous deep sedation did
occur significantly less frequently in the Dutch- than in
the French-speaking community, especially while admin-
istering food and fluid (8% versus 18%).
Discussion with patient
Questions concerning discussion of the decision with the
patient remained unanswered in one fifth of cases. In the
remaining cases, the decision was discussed in 36% of
cases, and 43% of these patients had made an explicit
request (Table 4). Seventy-five percent of the patients
where no discussion was reported were judged non-com-
petent to make decisions. We found no community differ-
ences regarding whether or not the decision was discussed
with the patient, whether he/she made an explicit request
or whether he/she was non-competent. No data were
available concerning the decision-making process of con-
tinuous deep sedation. No setting-specific differences
between the two communities were found (data not
shown).
Discussion
End-of-life decisions with possible, partly or explicitly life-
shortening intent occurred in approximately half of all
non-sudden deaths in Belgium. Intensified alleviation of
symptoms and non-treatment decisions were most preva-
lent, while euthanasia or physician-assisted suicide (PAS)
occurred in 1.3% of cases and life-ending drugs use with-
out explicit patient request in 1.6% of cases. Continuous
deep sedation until death occurred in one in ten non-sud-
den deaths. Although comparing with other studies is dif-
ficult due to other research designs, in general, the
relatively high occurrence of symptom alleviation, seda-
tion and non-treatment decisions, especially compared to
the use of lethal drugs, was also found in previous studies
in Belgium, and in several other European countries
[3,4,10]. Life-ending drug use without explicit patient
request was also found to be relatively high in previous
studies in the Dutch-speaking community of Belgium
compared to other countries in the world [3,4]. However,
we found some remarkable differences between the
Dutch- and French-speaking communities in type and
prevalence of certain end-of-life decisions, even after con-







Patient characteristicsa N % N % N %
Ageb 1–64 y 118 11.6 81 12.5 199 12.0
65–84 y 574 56.7 358 55.2 932 56.1
85 y+ 321 31.7 209 32.3 530 31.9
Sex Male 526 51.0 313 47.6 839 49.6
Female 506 49.0 345 52.4 851 50.4
Educational levelb Elementary or lower 431 46.3 235 40.9 666 44.3
Lower secondary 245 26.3 180 31.3 425 28.2
Higher secondary 173 18.6 113 19.7 286 19.0
Higher education 81 8.7 47 8.2 128 8.5
Cause of deathb Cardiovascular dis. 136 13.3 101 15.5 237 14.2
Malignancies 455 44.6 270 41.5 725 43.4
Respiratory dis. 96 9.4 61 9.4 157 9.4
Dis. nervous systemc 110 10.8 82 12.6 192 11.5
Other 223 21.9 137 21.0 360 21.5
Place of death Home or with family 226 21.9 177 26.9 403 23.8
Care home 276 26.7 176 26.7 452 26.7
Hospital 421 40.8 244 37.1 665 39.3
Palliative care unit 109 10.6 61 9.3 170 10.1
a p > .05 for all characteristics (Fishers' Exact test)
b Missing values for age n = 29; for level of education n = 185; for cause of death n = 19
c including strokePage 4 of 10
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with possible life-shortening effect in general were more
prevalent in the Dutch-speaking community, while the
practice of continuous deep sedation was more prevalent
in the French-speaking community. We could observe a
tendency towards higher frequencies of euthanasia/PAS in
the Dutch-speaking community, but differences were not
significant. Variations between communities did occur
according to care setting especially for non-treatment
decisions and continuous deep sedation. There were no
significant variations in the extent to which decisions were
discussed with the patients.
This is the first study on end-of-life decisions in Belgium
covering the whole country and the first to describe varia-
tions between two language communities in a country
where euthanasia is legal. Important strengths of the study
include the use of a nationwide and representative surveil-
lance network with a long history of registration research,
not selected on the basis of a specific interest in end-of-life
research [31,34]; the representativeness of the identified
sample of non-sudden deaths; and the quality of the
research procedures e.g. weekly registrations could limit
memory bias [4,39]. The percentage of non-sudden
deaths was also comparable to previous death certificate
studies [4].
This study also has limitations. Firstly, GPs were asked to
retrospectively indicate whether they or another physician
had taken an end-of-life decision. Underestimation is pos-
sible especially for patients dying in a hospital and in par-
ticular for specific types of decisions which can be seen as
part of routine clinical practice and are thus generally less
often discussed with other professionals e.g. intensified
symptom alleviation [3,18,19]. Results also confirmed
that missing data were highest for hospital deaths and for
the decision-making process of symptom alleviation.
However, it should be noted that a possible underestima-
tion of certain types of decision-making does not make
the intra-country comparisons less valid. It does make
comparisons with previous incidence studies in Flanders
using another research design [3,4] less feasible, especially
Table 2: Frequency of end-of-life decisions in non-sudden deaths in Belgium, according to community
Dutch-speaking community French-speaking community Belgium total
N % N % ORb 95%CI N % 95%CId
Most important end-of life decision that possibly hastened death (ELD)
Number of deaths studieda 1007 637 1644
Euthanasia/assisted suicidee 16 1.6 6 0.9 1.70 [0.66–4.36] 22 1.3 [0.8–2.0]
Administering life-ending drugs 
without explicit patient request
17 1.7 9 1.4 1.20 [0.53–2.71] 26 1.6 [1.0–2.3]
Intensified alleviation of 
symptoms
295 29.3 160 25.1 1.21 [0.96–1.53]c 455 27.7 [25.5–29.9]
Withholding or withdrawing of 
life-prolonging treatment
177 17.6 89 14.0 1.33 [0.999–1.77]c 266 16.2 [14.4–18.1]
Total ELD 505 50.1 264 41.4 1.43 [1.16–1.77] 769 46.8 [44.3–49.2]
Total ELD with partly or 
explicitly life-shortening intent
153 15.2 70 11.0 1.42 [1.05–1.93] 223 13.6 [11.9–15.3]
Continuous deep sedationf
Number of deaths studieda 999 630 1629
All sedation 82 8.2 95 15.1 0.50 [0.37–0.69] 177 10.9 [9.4–12.5]
forgoing artificial food/fluid 36 3.6 37 5.9 0.60 [0.37–0.96] 73 4.5 [3.5–5.6]
administering food/fluid 46 4.6 58 9.2 0.42 [0.28–0.64] 104 6.4 [5.2–7.7]
a Missing data: all questions concerning ELDs unanswered n = 46 (2.7%) (of which 43 cases had died in the hospital: 24 Dutch and 19 French-
speaking); question sedation unanswered n = 61 (of which 56 had died in a hospital: 29 Dutch and 27 French-speaking)
b Odds ratios based on logistic regression with community as predictor (French = ref cat) and controlling for patients' age, sex, educational level, 
cause of death, and place of death
c The probability was significant if alpha = .10 (i.e. level of the CI is 90%)
d Binomial Confidence Interval; exact method
e Physician-assisted suicide was limited to one case
f Sedation was provided in conjunction with any possibly death-hastened decision for 7.9%, and Dutch- and French-speaking communities did not 
differ.Page 5 of 10
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Table 3: Frequency of end-of-life decisions in non-sudden deaths according to community and setting in Belgium
Place of death Home or care home Hospital or palliative care unit
Dutch-speaking French-speaking Dutch-speaking French-speaking
N % N % OR [95%CI]a N % N % OR [95%CI]a
Euthanasia/assisted suicidec 8 1.6 4 1.1 1.41 [0.42–4.71] 8 1.6 2 0.7 2.28 [0.48–10.82]
Administering life-ending drugs 
without explicit patient request
10 2.0 7 2.0 1.00 [0.38–2.66] 7 1.4 2 0.7 1.99 [0.41–9.65]
Intensified alleviation of 
symptoms taking life-shortening 
into account
155 30.9 95 27.1 1.23 [0.95–1.60] 112 22.1 57 19.9 1.14 [0.80–1.63]
Intensified alleviation of 
symptoms with partly life-
shortening intent
18 3.6 5 1.4 2.47 [1.06–5.75] b 10 2.0 3 1.1 1.90 [0.52–6.97]
Non-treatment taking life-
shortening into account
54 10.8 30 8.6 1.30 [0.81–2.11] 31 6.1 12 4.2 1.49 [0.75–2.95]
Non-treatment with explicit life-
shortening intent
51 10.2 18 5.1 2.20 [1.24–3.91] 41 8.1 29 10.1 0.78 [0.47–1.29]
Total ELD 296 59.1 159 45.3 1.80 [1.36–2.40] 209 41.3 105 36.7 1.16 [0.85–1.57]
All sedation 22 4.4 29 8.2 0.51 [0.29–0.91] 60 12.0 66 23.7 0.45 [0.30–0.66]
Continuous deep sedation 
forgoing food/fluid
16 3.2 20 5.7 0.58 [0.33–1.02] b 20 4.0 17 6.1 0.64 [0.33–1.24]
Continuous deep sedation 
administrating food/fluid
6 1.2 9 2.6 0.45 [0.16–1.29] 40 8.0 49 17.6 0.42 [0.26–0.66]
a Odds ratios based on logistic regression with community as predictor (French = ref cat) and controlling for patients' age, sex, educational level, 
and cause of death.
b The probability was significant if alpha = .10 (i.e. level of the CI is 90%)
c Cases of euthanasia or assisted suicide were not reported for patients dying in a care home
Table 4: Discussion with patient of end-of-life decisions in Belgium, according to community
Dutch-speaking French-speaking Total for Belgium
Number of deaths studieda 412 191 603
Discussion with patientb % % %
Administering life-ending drugs without explicit patient request Discussed 37.5 33.3 36.0
Not discussed 62.5 66.7 64.0
Patient non-competent 100.0 83.3 93.8
Intensified alleviation of symptoms Discussed 30.8 23.3 28.5
Explicit request 38.6 25.0 35.1
Not discussed 69.2 76.7 71.5
Patient non-competent 67.7 67.5 67.7
Withholding or withdrawing of life-prolonging treatment Discussed 39.9 39.7 39.8
Explicit request 42.6 41.4 42.2
Not discussed 60.1 60.3 60.2
Patient non-competent 88.0 81.8 86.0
Total Discussed 37.1 32.5 35.7
Explicit request 45.1 38.7 43.3
Not discussed 62.9 67.5 64.3
Patient non-competent 76.3 73.2 75.3
a Missing values for discussion with patient: for all ELDs n = 166 (21%) (93 Dutch and 73 French-speaking) i.e. for administering life-ending drugs 
without explicit patient request n = 1, for intensified alleviation of symptoms n = 125, for withholding or withdrawing of life-prolonging treatment n 
= 40.
b p > .05 for all characteristics (Fishers' Exact test)
BMC Public Health 2009, 9:79 http://www.biomedcentral.com/1471-2458/9/79for these hospital deaths. Secondly, a possible selection or
recall bias due to the retrospective design cannot be
excluded. Thirdly, due to a low number of cases for some
decisions e.g. euthanasia, small differences between
groups might not have been identified. Fourthly, the high
percentage of missing data concerning the end-of-life
decision-making process – probably due to the difficult
instructions used – might have biased these results.
Fifthly, we did not measure differences in the patient's
symptom severity nor in the attitudes of physicians which
might have further explained the variations found. We
could only control for community differences in patients'
age, sex, educational level, cause of death, place of death
and possible interaction effects while other possible con-
founders were not measured. Finally, language was used
to differentiate between the two communities of Belgium,
but cannot be used to explain the differences we found.
Even though language and culture are strongly related, the
study of specific underlying cultural factors could have
explained the results more fully.
Even though Belgium is a country with one legal and gen-
eral healthcare system, the higher prevalence of possibly
life-shortening end-of-life decisions and lower prevalence
of continuous deep sedation in the Dutch-speaking com-
munity compared with the French-speaking is remarka-
ble. The difference remained present even after
controlling for possible variation in patient characteristics
such as age, sex, cause and place of death. Continuous
deep sedation is a specialist technique used to relieve
intolerable suffering and control refractory distressful
symptoms in the last phase of life [14]. Contrary to the
other end-of-life decisions where a possible life-shorten-
ing effect is always taken into account and sometimes
explicitly intended, a life-shortening effect is generally not
intended nor expected in cases of continuous deep seda-
tion, except if artificial food and fluid are forgone (i.e. ter-
minal sedation). In these latter cases, death generally is
expected and in some cases also intended [14,40,41].
Hence, in the Dutch-speaking community, physicians,
patient or their families seem to be more readily prepared
to make or ask for life-shortening decisions than in the
French-speaking community. In the French-speaking
community, they seem to prefer to prolong life for longer,
continuing available treatments (including the use of sed-
ative drugs) and to intervene later in the dying process
using less direct ways.
This finding corresponds to previous reports on end-of-
life care in Belgium. Compared to patients in the Dutch-
speaking community, patients in the French-speaking
community more often receive possibly life-prolonging
treatments and treatment goals are aimed at cure or pro-
longing life for a longer time in the final three months of
life [38]. Additionally, studies from other domains have
shown a higher consumption of technological specialist
care in the French-speaking part [30]. This stronger appre-
ciation of curative, technological and specialist medicine
in the French-speaking community might explain the
rarer use of life-shortening decisions and preference
towards specialist techniques such as continuous deep
sedation. This might be rooted in a general difference in
medical culture between the two communities. Since
other cross-country studies have shown that life-prolong-
ing treatments (e.g. CPR) and sedative techniques are used
more often in southern European countries while possi-
bly life-shortening decisions are more prevalent in several
northern European countries [4,14,20,21,26,42,43], the
French-speaking community of Belgium seems more
closely related to the Latin-French culture in southern
European countries, while the Dutch-speaking commu-
nity corresponds more closely to the northern Germanic
European countries.
Therefore, the fact that the public debate on life-shorten-
ing and the regulation of euthanasia started early in the
Netherlands [44] – lying north of Belgium and where the
same language is spoken as in the Dutch-speaking part of
Belgium – might have had an early influence on the
Dutch-speaking community in Belgium, which was prob-
ably absent in the French-speaking community, leading to
a higher tendency towards life-shortening decision-mak-
ing [44].
Concerning euthanasia/PAS, there was a tendency
towards a higher prevalence in the Dutch-speaking com-
munity but differences were not statistically significant,
possibly due to the small number of observed cases. How-
ever, actual differences apparently are not large enough to
explain the disproportionate percentages observed in the
legal notification rate of euthanasia, especially in the
home or care home settings [27-29]. Thus, French-speak-
ing physicians, especially general practitioners, seem to
report their cases less often to the Federal Evaluation and
Control Committee on Euthanasia than the Dutch-speak-
ing. Unfortunately, reasons for this could not be explored.
Perhaps French-speaking GPs were less well-informed
about the law as the media coverage on euthanasia is
higher and training initiatives for physicians are more
present in the Dutch-speaking community [45]. Alterna-
tively, culturally determined attitudes towards legal evalu-
ation of medical practices might differ between the two
communities. This finding warrants further investigation
of French-speaking physicians' attitudes towards the law
on euthanasia.
In this study, some interesting setting-specific differences
also became apparent. Firstly, analysis showed a higher
prevalence of non-treatment decisions with explicit life-
shortening effect in the homes/care homes in the Dutch-Page 7 of 10
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ous deep sedation especially while forgoing artificial
food/fluid (terminal sedation) in the French-speaking
community, an effect not found in hospitals. Possibly,
French-speaking GPs postpone any decision about
whether or not a treatment is futile for longer, or let things
take their course for a longer time and are then more read-
ily prepared to use sedative drugs instead. Forgoing food/
fluid might be a logical consequence of sedative therapy
intending to let a patient pass away gently and not a deci-
sion primarily intended to shorten life [14,40]. This might
partly be explained by the fact that training and consulta-
tion initiatives concerning end-of-life decision-making
(e.g. communication guidelines, training of physicians to
consult colleague physicians) more often originated in the
Dutch-speaking community setting in Belgium [45]. Also,
preferences for certain end-of-life practices might have a
more profound impact in general practice where physi-
cians need to make decisions on their own, compared
with hospitals where physicians work within well-defined
structures with specific policies regarding complex
medico-ethical decisions such as the futility of treatments.
However, these hypotheses need more research before
definite conclusions can be drawn.
Secondly, continuous deep sedation while administering
food/fluid was found to occur noticeably more in hospital
settings in the French-speaking community (18% of all
non-sudden deaths). Possibly, feeding or hydrating the
patient indicates that the physician wants to keep the
patient alive [14]. Therefore, the finding might be
explained by the strong orientation towards cure in hospi-
tal cultures [46] fortified by the general preference for
technological curative medicine in the southern commu-
nity [20,21,30,38,43]. French-speaking hospital physi-
cians seem to reach out for this treatment option sooner
or more easily than Dutch-speaking physicians to treat
complex problems of terminal patients.
Conclusion
Even within one country with one legal system and the
same basic healthcare options and structures, systematic
differences in prevalence and legal reporting of medical
end-of-life decisions can occur. Societal and cultural dif-
ferences between both communities possibly play an
important role in determining responses to end-of-life
suffering. Further anthropological study is needed to shed
light on the mechanisms underlying differences in end-of-
life decision-making.
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